Evidence map›Paper›PMID 41080108›Full record

ReviewSeminars in interventional radiology2025

Fundamentals of Pediatric Cancer: How Pediatric Pathology and Infrastructure of Clinical Trials Impact Contemporary Interventional Oncology in Children.

Sarah G Mitchell, Kathryn S Sutton, Thomas Cash

Abstract readReview
In one paragraph

Review in Seminars in interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sarah G MitchellDepartment of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.
Kathryn S SuttonDepartment of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.
Thomas CashDepartment of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pediatric cancer, though rare compared with adult malignancy, remains a significant cause of morbidity and mortality, with approximately 15,000 new diagnoses and over 1,500 deaths annually in the United States. Advances in multimodal therapy and cooperative group clinical trials have improved overall survival rates to over 80% in developed nations. Pediatric interventional oncology, a subset of pediatric interventional radiology (IR), has expanded beyond its role in biopsy and vascular access to include tumor-targeted and supportive care interventions. However, challenges in the field remain, including less pediatric-specific data and limited access to pediatric-trained interventional radiologists. Multidisciplinary collaboration is important for the integration of pediatric interventional oncology as a key component of pediatric cancer treatment.

Indexed as

pediatric cancerpediatric interventional oncologypediatric interventional radiologytumor biopsy

Identifiers

PMID41080108
PMCPMC12513749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.